Search research articles
Contact Us
Filters
Showing results (121-130 of 164) with videos related to
Page
of 17
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Targeting IL-1/IRAK1/4 signaling in Acute Myeloid Leukemia Stem Cells Following Treatment and Relapse
Tzu-Chieh Ho, Mark W LaMere, Hiroki Kawano, et al.
Cell Metabolism
|
January 30, 2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD<sup>+</sup> to eradicate KRAS-driven AML
Ang Jia, Xiaowen Zhang, Ji-Hao Zhou, et al.
Blood
|
July 17, 2016
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
Tzu-Chieh Ho, Mark LaMere, Brett M Stevens, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials
Wendy A Woodward, Robert G Bristow, Michael F Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2016
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
Mark A Gregory, Angelo D'Alessandro, Francesca Alvarez-Calderon, et al.
Nature Medicine
|
November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
Daniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
The Journal of Biological Chemistry
|
November 27, 2016
Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells
Shanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
The Journal of Biological Chemistry
|
August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Cancer Cell
|
October 2, 2018
Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells
Haobin Ye, Biniam Adane, Nabilah Khan, et al.
Cancer Discovery
|
October 8, 2020
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG
Haobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 164) with videos related to
Sort By:
Page
of 17
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Targeting IL-1/IRAK1/4 signaling in Acute Myeloid Leukemia Stem Cells Following Treatment and Relapse
Tzu-Chieh Ho, Mark W LaMere, Hiroki Kawano, et al.
Cell Metabolism
|
January 30, 2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD<sup>+</sup> to eradicate KRAS-driven AML
Ang Jia, Xiaowen Zhang, Ji-Hao Zhou, et al.
Blood
|
July 17, 2016
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
Tzu-Chieh Ho, Mark LaMere, Brett M Stevens, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials
Wendy A Woodward, Robert G Bristow, Michael F Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2016
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
Mark A Gregory, Angelo D'Alessandro, Francesca Alvarez-Calderon, et al.
Nature Medicine
|
November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
Daniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
The Journal of Biological Chemistry
|
November 27, 2016
Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells
Shanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
The Journal of Biological Chemistry
|
August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Cancer Cell
|
October 2, 2018
Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells
Haobin Ye, Biniam Adane, Nabilah Khan, et al.
Cancer Discovery
|
October 8, 2020
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG
Haobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Page
of 17